|HBM BioCapital II fund, 2/12||€90M|
HBM Partners is among the global leaders in Life Science-focused investing with approximately USD 1 billion under management. HBMâ€™s advisory business was founded in 2001 with the vision to invest across the life cycle of healthcare companies, from venture backed early-stage all the way to listed companies.
|Odyssey Thera||2/13||Venture Round||$2.8M||3|
|Gemin X Pharmaceuticals||7/08||Series C||$38M||13|